What’s New

*** PRESS RELEASE*** Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

WASHINGTON – On Thursday, April 6 the Institute for Patient Access and Biologics Prescribers Collaborative, a project of the Alliance for Patient Access, will host

Read More

Access Worries Persist after ICER’s Arthritis Report, Meeting

A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients. The

Read More

***PRESS RELEASE*** Georgia Health Plans Reject Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

Will Political Finger-pointing Dampen Zika Vaccine Efforts?

A vaccine for Zika virus is in the works with the potential to halt the devastating disease that’s spread to more than 5,000 people and

Read More

***PRESS RELEASE*** New York Health Plans Reject More than 1/3 Claims for High Cholesterol Treatment

  New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations.  WASHINGTON – The Institute for Patient Access released a new Health

Read More

Statement from Brian Kennedy on Friday’s ICER meeting in Boston

STATEMENT FROM BRIAN KENNEDY, EXECUTIVE DIRECTOR, ALLIANCE FOR PATIENT ACCESS: Evaluating cost effectiveness of breakthrough therapies like TIMs for rheumatoid arthritis is an important exercise.

Read More

Can the Gas Company’s Model Help Seniors Manage Rx Co-pays?

Senior citizens can face crippling out-of-pocket costs for their Medicare Part D prescription drugs. But now the University of Pennsylvania’s Perelman School of Medicine has

Read More

***PRESS RELEASE*** Alabama Health Plans Reject Over Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

Cardiac Meds Cut Patients’ Heart Attack Risk – Or Your Money Back

Cholesterol-lowering drugs known as PCSK9 inhibitors can reduce the risk of heart, stroke and cardiovascular death by 20 percent, new research confirms.  And if patients

Read More

***PRESS RELEASE*** Physician Group Leader Issues Statement of Support for FDA Commissioner Nominee Scott Gottlieb, MD

WASHINGTON – The Alliance for Patient Access (AfPA) issued the following statement today on President Donald Trump’s nomination of Scott Gottlieb, MD, for commissioner of

Read More
Back to Top